
Mushood Ahmed
@mushoodch
MS-5/Clinical Researcher
ID: 1801210975615410176
13-06-2024 11:12:27
39 Tweet
82 Takipçi
548 Takip Edilen


Type 2 Diabetes Mellitus–Related Mortality in the United States, 1999 ... sciencedirect.com/science/articl… Mushood Ahmed JACC Journals


Our new publication in JACC Journals! 📈 2M+ deaths from #T2DM in US (1999-2023) 🚨 Spike during COVID ❤️ 626K+ CVD-linked deaths 🔗 Full study: sciencedirect.com/science/articl… Jamal Rana, MD Steve Greene Marat Fudim, MD MHS Robert Mentz, MD Gregg Fonarow MD


✨ Our latest paper published in the official journal of AHA/SVIN, and simultaneously presented at the European Academy of Neurology (EAN) Congress 2025 Mushood Ahmed Faizan A Malik, MD Raheel Ahmed Majid Toseef Aized Gregg Fonarow MD SVIN Stroke: Vascular and Interventional Neurology ahajournals.org/doi/10.1161/SV…


Our paper out today in International Journal of Cardiology Heart&Vasc led by a super ⭐️ team! ⚡️In past 25 years #CardiogenicShock related mortality in heart failure team has increased nearly 4 fold! 💔 ⚡️Mortality notably higher in #rural areas.


Our new publication in RPTH ! 🩸 Reduced-dose DOACs for extended #VTE treatment ⚖️ Similar efficacy to full-dose 🛡️ Lower bleeding risk (29%↓ major bleeds) 🔗 Full study: sciencedirect.com/science/articl… Raheel Ahmed Jamal Rana, MD Steve Greene Marat Fudim, MD MHS Robert Mentz, MD Gregg Fonarow MD


Our meta-analysis of 3945 CCS patients had also demonstrated better outcomes with OAC monotherapy! Raheel Ahmed Mahboob Alam Jamal Rana, MD SABOURETCardiologist Gregg Fonarow MD #ESCCongress


Intravenous thrombolysis prior to mechanical thrombectomy demonstrated comparable outcomes to thrombectomy alone in terms of functional recovery, recanalization, mortality, and hemorrhage. Ameer E. Hassan Gregg Fonarow MD Raheel Ahmed Mushood Ahmed Muhammad Shakir


Our #editorial - Time to Disaggregate #AsianAmerican to Address Disparities in Heart Failure Risk in JACC Journals out. ⚡️For context the term #Asians typically refers to people originating from continent of Asia, which includes East, Southeast, South, Central, and West Asia,


Reduced-dose vs full-dose direct oral anticoagulants for extended treatment of venous thromboembolism: a meta-analysis of randomized controlled trials - Research and Practice in Thrombosis and Haemostasis rpthjournal.org/article/S2475-… Marat Fudim, MD MHS Robert Mentz, MD



New publication in AHJPlus 📊 Meta-analysis (16 RCTs, n=20,601) 🩺 Colchicine ↓ MI risk ⚖️ No effect on all-cause/CV death ⚠️ ↑ GI AEs & discontinuations 🔗 doi.org/10.1016/j.ahjo… Jamal Rana, MD Marat Fudim, MD MHS Gregg Fonarow MD





Updated meta-analysis of RCTs Oral anticoagulant monotherapy in patients with chronic coronary disea... sciencedirect.com/science/articl… Mushood Ahmed American Journal of Medicine

New publication in American Journal of Medicine 📊 Meta-analysis (5 RCTs, n=4,964) 👥 Patients: chronic coronary disease (most post-PCI and with Afib) 💊 OAC monotherapy ↓ bleeding risk ⚖️ No ↑ in MI, stroke, or death 🔗 doi.org/10.1016/j.amjm… Jamal Rana, MD Gregg Fonarow MD


This is an extraordinary report from Institute for Health Metrics and Evaluation (IHME) and published in JACC Journals; it demonstrates that cardiovascular disease is a global scourge. And we are failing to leverage what we know to save lives. jacc.org/doi/10.1016/j.…


Muthu Vaduganathan Steve Greene Andrew J Sauer MD Anu Lala (Anuradha Lala-Trindade) Shelley Zieroth Javed Butler Pedro Schwartzmann, MD, PhD, FESC 🇧🇷 Jonathan Davis, MD, MPHS HFAPresident Ankeet S. Bhatt, MD, MBA BB in-hospital in HFrEF markedly improves use, adherence, persistence, and clinical outcomes including lower all-cause mortality This Rx is the single most effective mortality reducing therapy in 🏨 HFrEF and Class 1 in guidelines across the world for in🏨 use
